Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy-Reference-Cited by-同舟云学术

Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy

Published:2018-08-03 Issue:60 Volume:9 Page:31590-31605
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Bordron Anne¹,Bagacean Cristina¹²,Mohr Audrey¹,Tempescul Adrian¹³,Bendaoud Boutahar¹²,Deshayes Stéphanie¹,Dalbies Florence³,Buors Caroline⁴,Saad Hussam³,Berthou Christian¹³,Pers Jacques-Olivier¹,Renaudineau Yves¹²

Affiliation:

1. U1227 B Lymphocytes and Autoimmunity, Université de Brest, INSERM, IBSAM, Labex IGO, Networks IC-CGO and REpiCGO from ‘Canceropole Grand Ouest, Brest, France

2. Laboratory of Immunology and Immunotherapy, CHRU Brest, Hôpital Morvan, Brest, France

3. Department of Haematology, CHRU Brest, Hôpital Morvan, Brest, France

4. Laboratory of Haematology, CHRU Brest, Hôpital Morvan, Brest, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenylboronic acid-functionalized biomaterials for improved cancer immunotherapy via sialic acid targeting;Advances in Colloid and Interface Science;2024-11

2. Efficacy and safety of novel biologics in the treatment of lupus nephritis based on registered clinical trials: a systematic review and network meta-analysis;Clinical and Experimental Medicine;2023-07-18

3. Altered Glycosylation in Progression and Management of Bladder Cancer;Molecules;2023-04-13

4. Sialylation regulates migration in chronic lymphocytic leukemia;Haematologica;2023-02-09

5. Exploring complement-dependent cytotoxicity by rituximab isotypes in 2D and 3D-cultured B-cell lymphoma;BMC Cancer;2022-06-20